Sandoval K, Witt K
Pharmacol Rev. 2024; 76(6):1291-1325.
PMID: 39013601
PMC: 11549939.
DOI: 10.1124/pharmrev.124.001117.
Logue M, Dasgupta S, Farrer L
J Clin Med. 2023; 12(16.
PMID: 37629231
PMC: 10455208.
DOI: 10.3390/jcm12165189.
Gonzalez-Alcocer A, Duarte-Jurado A, Soto-Dominguez A, Loera-Arias M, Villarreal-Silva E, Saucedo-Cardenas O
Int J Mol Sci. 2023; 24(2).
PMID: 36674772
PMC: 9867532.
DOI: 10.3390/ijms24021256.
Liu Y, Xiao X, Liu H, Liao X, Zhou Y, Weng L
Front Aging Neurosci. 2022; 14:1013295.
PMID: 36313020
PMC: 9616047.
DOI: 10.3389/fnagi.2022.1013295.
Rubin L, Ingram L, Resciniti N, Ashford-Carroll B, Leith K, Rose A
Front Public Health. 2022; 9:784958.
PMID: 35004586
PMC: 8739784.
DOI: 10.3389/fpubh.2021.784958.
Amyloid-β: a potential link between epilepsy and cognitive decline.
Romoli M, Sen A, Parnetti L, Calabresi P, Costa C
Nat Rev Neurol. 2021; 17(8):469-485.
PMID: 34117482
DOI: 10.1038/s41582-021-00505-9.
Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.
Kazim S, Seo J, Bianchi R, Larson C, Sharma A, Wong R
eNeuro. 2021; 8(2).
PMID: 33741601
PMC: 8174042.
DOI: 10.1523/ENEURO.0418-20.2020.
Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease.
Bi C, Bi S, Li B
Aging Dis. 2019; 10(2):383-403.
PMID: 31011484
PMC: 6457050.
DOI: 10.14336/AD.2018.0425.
Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.
Hunter S, Brayne C
Mol Psychiatry. 2017; 23(1):81-93.
PMID: 29112196
DOI: 10.1038/mp.2017.218.
Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.
Nsongo A, Carrasquillo M, Wang X, Nguyen T, Asmann Y, Younkin S
J Alzheimers Dis. 2017; 56(4):1215-1222.
PMID: 28106563
PMC: 6774612.
DOI: 10.3233/JAD-161185.
Network abnormalities and interneuron dysfunction in Alzheimer disease.
Palop J, Mucke L
Nat Rev Neurosci. 2016; 17(12):777-792.
PMID: 27829687
PMC: 8162106.
DOI: 10.1038/nrn.2016.141.
Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study.
Sancheti H, Patil I, Kanamori K, Brinton R, Zhang W, Lin A
J Cereb Blood Flow Metab. 2014; 34(11):1749-60.
PMID: 25099753
PMC: 4269751.
DOI: 10.1038/jcbfm.2014.137.
Potential Similarities in Temporal Lobe Epilepsy and Alzheimer’s Disease: From Clinic to Pathology.
Li B, Chen S
Am J Alzheimers Dis Other Demen. 2014; 30(8):723-8.
PMID: 24906967
PMC: 10852563.
DOI: 10.1177/1533317514537547.
A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman.
Ting S, Benzinger T, Kepe V, Fagan A, Coppola G, Porter V
J Alzheimers Dis. 2014; 40(2):271-5.
PMID: 24413619
PMC: 3972314.
DOI: 10.3233/JAD-131844.
Epileptic seizures in AD patients.
Larner A
Neuromolecular Med. 2009; 12(1):71-7.
PMID: 19557550
DOI: 10.1007/s12017-009-8076-z.
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.
Kalaria R, Maestre G, Arizaga R, Friedland R, Galasko D, Hall K
Lancet Neurol. 2008; 7(9):812-26.
PMID: 18667359
PMC: 2860610.
DOI: 10.1016/S1474-4422(08)70169-8.
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.
Palop J, Chin J, Roberson E, Wang J, Thwin M, Bien-Ly N
Neuron. 2007; 55(5):697-711.
PMID: 17785178
PMC: 8055171.
DOI: 10.1016/j.neuron.2007.07.025.